Xu, H., Wang, D., Ramponi, C., Wang, X., & Zhang, H. (2022). The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease. Int J Drug Discov Pharm.

Xu, Honglin, Dingwei Wang, Chiara Ramponi, Xin Wang, ja Hongyuan Zhang. "The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease." Int J Drug Discov Pharm 2022.

Xu, Honglin, et al. "The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease." Int J Drug Discov Pharm 2022.